<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">21595779</PMID>
      <DateCompleted>
        <Year>2012</Year>
        <Month>10</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1442-2050</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2012</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</Title>
          <ISOAbbreviation>Dis Esophagus</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Kagoshima consensus on esophageal achalasia.</ArticleTitle>
        <Pagination>
          <StartPage>337</StartPage>
          <EndPage>348</EndPage>
          <MedlinePgn>337-48</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1442-2050.2011.01207.x</ELocationID>
        <Abstract>
          <AbstractText>Esophageal achalasia is a primary esophageal motility disorder characterized by lack of peristalsis and a lower esophageal sphincter that fails to relax appropriately in response to swallowing. This article summarizes the most salient issues in the diagnosis and management of achalasia as discussed in a symposium that took place in Kagoshima, Japan, in September 2010 under the auspices of the International Society for Diseases of the Esophagus.</AbstractText>
          <CopyrightInformation>© 2011 Copyright the Authors. Journal compilation © 2011, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Triadafilopoulos</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Stanford University School of Medicine, Stanford, CA 94305, USA. vagt@stanford.edu</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boeckxstaens</LastName>
            <ForeName>G E</ForeName>
            <Initials>GE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gullo</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patti</LastName>
            <ForeName>M G</ForeName>
            <Initials>MG</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pandolfino</LastName>
            <ForeName>J E</ForeName>
            <Initials>JE</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kahrilas</LastName>
            <ForeName>P J</ForeName>
            <Initials>PJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duranceau</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jamieson</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaninotto</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016446">Consensus Development Conference</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2011</Year>
          <Month>05</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Dis Esophagus</MedlineTA>
        <NlmUniqueID>8809160</NlmUniqueID>
        <ISSNLinking>1120-8694</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009465">Neuromuscular Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.24.69</RegistryNumber>
          <NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D019274" MajorTopicYN="N">Botulinum Toxins, Type A</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002404" MajorTopicYN="N">Catheterization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004931" MajorTopicYN="N">Esophageal Achalasia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004944" MajorTopicYN="N">Esophagoplasty</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009465" MajorTopicYN="N">Neuromuscular Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2011</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2011</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">21595779</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1442-2050.2011.01207.x</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
